Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans

European Journal of Clinical Investigation

Volumn 40, Issue 3, 2010, Pages 195-202

  Pham, I ^a,b   Wuerzner, G ^c,d   Richalet, J P ^a,e   Peyrard, S ^c   Azizi, M ^c,d,f  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e AVICENNE HOSPITAL   (France)

^f INSERM   (France)

Author keywords

Endothelin 1; Hypoxia; Pulmonary hypertension

Indexed keywords

BOSENTAN; PLACEBO;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOCARDIOGRAPHY; EXERCISE; HEART HEMODYNAMICS; HEART OUTPUT; HEART RIGHT VENTRICLE FUNCTION; HUMAN; HUMAN EXPERIMENT; HYPOXIA; LUNG ARTERY PRESSURE; LUNG VASOCONSTRICTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, ORAL; ADULT; ANOXIA; ANTIHYPERTENSIVE AGENTS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CARDIAC OUTPUT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; EXERCISE; HUMANS; MALE; MIDDLE AGED; OXYGEN; PULMONARY ARTERY; PULMONARY CIRCULATION; RECEPTORS, ENDOTHELIN; SULFONAMIDES;

EID: 77649214842     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02254.x     Document Type: Article

References (26)

1. Richalet JP. High altitude pulmonary oedema: still a place for controversy? Thorax 1995 50 : 923 929.
2. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001 345 : 107 114.
3. Oelz O, Maggiorini M, Ritter M, Waber U, Jenni R, Vock P et al. Nifedipine for high altitude pulmonary oedema. Lancet 1989 2 : 1241 1244.
4. Antezana AM, Antezana G, Aparicio O, Noriega I, Velarde FL, Richalet JP. Pulmonary hypertension in high-altitude chronic hypoxia: response to nifedipine. Eur Respir J 1998 12 : 1181 1185.
5. Schneider JC, Blazy I, Dechaux M, Rabier D, Mason NP, Richalet JP. Response of nitric oxide pathway to L-arginine infusion at the altitude of 4,350 m. Eur Respir J 2001 18 : 286 292.
6. Richalet JP, Gratadour P, Robach P, Pham I, Dechaux M, Joncquiert-Latarjet A et al. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med 2005 171 : 275 281.
7. Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Bohm T, Bernheim A et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006 145 : 497 506.
8. Eddahibi S, Raffestin B, Clozel M, Levame M, Adnot S. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am J Physiol 1995 268 : H828 35.
9. Willette RN, Ohlstein EH, Mitchell MP, Sauermelch CF, Beck GR, Luttmann MA et al. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog. J Pharmacol Exp Ther 1997 280 : 695 701.
10. Goerre S, Wenk M, Bartsch P, Luscher TF, Niroomand F, Hohenhaus E et al. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 1995 91 : 359 364.
11. Sartori C, Vollenweider L, Loffler BM, Delabays A, Nicod P, Bartsch P et al. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 1999 99 : 2665 2668.
12. Modesti PA, Vanni S, Morabito M, Modesti A, Marchetta M, Gamberi T et al. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation 2006 114 : 1410 1416.
13. Faoro V, Boldingh S, Moreels M, Martinez S, Lamotte M, Unger P et al. Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia. Chest 2009 135 : 1215 1222.
14. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002 346 : 896 903. (Pubitemid 34984638)
15. Allemann Y, Hutter D, Lipp E, Sartori C, Duplain H, Egli M et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA 2006 296 : 2954 2958.
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989 2 : 358 367.
17. Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 2003 41 : 1021 1027.
18. Zavorsky GS, Cao J, Mayo NE, Gabbay R, Murias JM. Arterial versus capillary blood gases: a meta-analysis. Respir Physiol Neurobiol 2007 155 : 268 279.
19. Dorrington KL, Clar C, Young JD, Jonas M, Tansley JG, Robbins PA. Time course of the human pulmonary vascular response to 8 hours of isocapnic hypoxia. Am J Physiol 1997 273 : H1126 34.
20. Grunig E, Mereles D, Hildebrandt W, Swenson ER, Kubler W, Kuecherer H et al. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol 2000 35 : 980 987.
21. Huez S, Faoro V, Vachiery JL, Unger P, Martinot JB, Naeije R. Images in cardiovascular medicine. High-altitude-induced right-heart failure. Circulation 2007 115 : e308 9.
22. Takahashi H, Soma S, Muramatsu M, Oka M, Ienaga H, Fukuchi Y. Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery. Eur Respir J 2001 18 : 5 14.
23. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994 199 : 1461 1465.
24. Weber C, Schmitt R, Birnboeck H, Hopfgartner G, van Marle SP, Peeters PA et al. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Clin Pharmacol Ther 1996 60 : 124 137.
25. Bohm F, Pernow J, Lindstrom J, Ahlborg G. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men. Clin Sci (Lond) 2003 104 : 143 151.
26. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003 138 : W1 12.